B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children

Pediatrics

Volumn 121, Issue 6, 2008, Pages

  Maher, Kevin O ^a,c   Reed, Heather ^a   Cuadrado, Angel ^a   Simsic, Janet ^a   Mahle, William T ^a   Deguzman, Michael ^a   Leong, Traci ^b   Bandyopadhyay, Subhankar ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c SIBLEY HEART CENTER CARDIOLOGY   (United States)

Author keywords

B type natriuretic peptide; Congenital; Critical; Diagnosis; Emergency; Heart; Pediatric; Presentation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ARTICLE; BLOOD LEVEL; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CRITICAL ILLNESS; DISEASE MARKER; EMERGENCY WARD; EVALUATION; HEALTH CARE; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; LEFT CORONARY ARTERY; LUNG VEIN DRAINAGE ANOMALY; PATENT DUCTUS ARTERIOSUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PULMONARY ARTERY; RESPIRATORY TRACT INFECTION; ADOLESCENT; BLOOD; CHILD; EMERGENCY; INFANT; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; EMERGENCIES; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; NATRIURETIC PEPTIDE, BRAIN;

EID: 48949099260     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1856     Document Type: Article

References (31)

1. Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects-United States, 2003. MMWR Morb Mortal Wkly Rep. 2007;56(2):25-29
2. Kain ZN, Caldwell-Anders AA. What pediatricians should know about child-related malpractice payments in the United States. Pediatrics. 2006;118(2):464-468
3. Costello J, Goodman D, Green T. A review of the natriuretic hormone system's diagnostic and therapeutic potential in critically ill children. Pediatr Crit Care Med. 2006;7(4):308-318
4. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87(4): 1402-1412
5. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993;76(1):91-96
6. Zellner C, Protter A, Ko E, et al. Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries. Am J Physiol. 1999;276(3 pt 2):H1049-H1057
7. Song DL, Kohse KP, Murad F. Brain natriuretic factor: augmentation of cellular cyclic GMP, activation of particulate guanylate cyclase and receptor binding. FEBS Lett. 1988;232(1): 125-129
8. Munzel T, Feil R, Mulsch A, Lohmann SM, Hofmann F, Walter U. Physiology and pathophysiology of vascular signaling controlled by guanosine 3',5'-cyclic monophosphate-dependent protein kinase [published correction appears in Circulation. 2003;108(25):3165]. Circulation. 2003;108(18):2172- 2183
9. Maisel A, Krishnaswamy P, Nowak R, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167
10. McCullough P, Nowak R, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from the Breathing Not Properly (BNP) multinational study. Circulation. 2002;106(4):416-422
11. Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet. 1994; 343(8895):440-444
12. Law Y, Keller B, Feingold B, Boyle G. Usefulness of plasma B-Type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenial heart disease. Am J Cardiol. 2005;95(4):474-478
13. Koch, A, Zink S, Singer H. B-type natriuretic peptide in pae- diatric patients with congenital heart disease. Eur Heart J. 2006; 27(7):861-866
14. Mir T, Falkenberg J, Friedrich B, et al. Levels of brain natri- uretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiol Young. 2005;15(4): 396-401
15. Claudius I, Lan Y, Chang R, Wetzel G, Alejos J. Usefulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients. Am J Cardiol. 2003;92(11):1368-1370
16. Choi B, Lee K, Eun B, et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics. 2005;115(3). Available at: www.pediatrics.org/cgi/content/ full/115/3/e255
17. Nir A, Nasser N. Clinical value of NT-Pro BNP and BNP in pediatric cardiology. J Card Fail. 2005;11(5 supp1):S76-S80
18. Mir TS, Marohn S, Laer S, Eiselt M, Grollmus O, Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics. 2002;110(6). Available at: www.pediatrics.org/cgi/ content/full/110/6/e76
19. Cowley C, Bradley J, Shaddy R. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol. 2004;25(4): 336-340
20. BNP Test for Rapid Quantification of B-Type Natriuretic Peptide [package insert]. San Diego, CA: Biosite Inc
21. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clo- pton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002; 39(2):202-209
22. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med. 2001;39(7): 571-588
23. Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart. 2003;89(8): 875-878
24. Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol. 2004;25(4):341-346
25. Cohen S, Springer C, Avital A, et al. Amino-terminal pro- brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress? Pediatrics. 2005;115(5):1347-1350
26. Sanjeev S, Pettersen M, Lua J, Thomas R, Shankaran S, L'Ecuyer T. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol. 2005;25(11):709-713
27. Reynolds E, Ellington J, Vranicar M, et al. Brain-type natri- uretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics. 2004; 114(5):1297-1304
28. Mahle W, Forkey H, Wernovsky G, et al. Sepsis, septic shock, acute abdomen? The ability of cardiac disease to mimic other medical illness. Pediatr Emerg Care. 1996;12(4):317-324
29. Malec E, Januszewska K, Kolcz J, et al. Factors influencing early outcome of Norwood procedure for hypoplastic left heart syndrome. Eur J Cardiothorac Surg. 2000;18(2):202-206
30. Licht, Wang J, Silversre DW, et al. Preoperative cerebral blood flow is diminished in neonate with severe congenital heart defects. J Thorac Cardiovasc Surg. 2004;128(6):841-849
31. Fried I, Bar-Oz, Algur N, et al. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction. Pediatrics. 2006;118(4). Available at: www.pediatrics.org/cgi/content/full/118/4/e1165